Search
Menu
Hamamatsu Corp. - Earth Innovations LB 2/24

UE LifeSciences Inc.

Facebook X LinkedIn Email
Medical device manufacturer UE LifeSciences Inc. of Philadelphia received market clearance from the FDA for its NoTouch BreastScan device. The contact-free breast-imaging tool was cleared by the FDA specifically for adjunctive diagnostic screening for breast cancer. The imaging system incorporates patent-pending dual-infrared detector design. The company says the tool dynamically analyzes temperature pixels from various infrared frames to create a real-time objective report for the physician. UE plans to offer NoTouch BreastScan services to clinics in the US beginning in the New York, New Jersey and Pennsylvania regions.
Gentec Electro-Optics Inc   - Measure Your Laser MR

Published: May 2012
AmericasBiophotonicsbreast cancer detectionbreast cancer screeningbreast imagingBusinessdiagnostic screening breast cancerearly breast cancerFDAImaginginfrared imaging system breast cancerNew JerseyNew YorkNoTouch BreastScanPennsylvaniaRapidScanSensors & DetectorsUE LifeSciencesUS Food and Drug Administration

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.